2012
DOI: 10.1016/j.jval.2012.03.863 View full text |Buy / Rent full text
|
|

Abstract: care environment, and data analytics. CONCLUSIONS: The integration of pharmacogenomic testing with real-world studies offers an important opportunity to identify sub-groups of patients for whom treatment is more effective in terms of clinical, and safety outcomes. Alongside resource utilization and cost of care data, this evidence can be used to populate cost-effectiveness and other health economic analyses to inform physician and payer decision-making. OBJECTIVES:Retrospective database studies commonly use an… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles